Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort study

Background The optimal therapeutic regimen for children at onset of idiopathic nephrotic syndrome (INS) is still under debate. A better knowledge of the disease’s course is necessary to design more appropriate and/or personalized treatment protocols.